According to the latest market research report, published by KD
Market Insights covers a detailed analysis of, “Multiplex Assay Market 2019: Market Size,
Trends & Opportunity Outlook – Forecast to 2026.” The study comprises of
major industry trends and insights that play an important role in the market
growth. Also, the report covers forecast revenue growth at global, regional and
country levels, providing a detailed analysis of the industry.
The global multiplex
assays market accounted for $73.2 million in 2018, and is expected to
reach $123.1 million by 2026, growing at a CAGR of 6.6% from
2019 to 2026. Multiplex immunoassays conjugates assays for several target
analytes in a single reaction volume, minimizing workflow and sample volume
difficulties. In addition, this assay provides a gain in assay dynamic range,
and is used to amplify multiple targets in a polymerase chain reaction (PCR)
and collect more information from minute quantities of proteins or other
analytes in lesser time as compared to conventional methods such as singleplex
ELISA. Multiplex assays find its application in pathogen identification,
mutation analysis, RNA detection, gene detection analysis, linkage analysis,
forensic studies, and others.
Multiplex assays hold
enormous potential in the R&D of drugs for the treatment of diseases, such
as cancer and cardiovascular diseases that drives the market growth for theses
assays. For instance, bead based Luminex xMAP multiplex assay provides a platform
for cancer biomarker assays, which are compatible with plasma, serum, cultured
cells, and other biological samples. In addition, surge in adoption of
multiplex assays to reduce operation costs and rise in adoption of personalized
medicines are anticipated to boost the market growth. However, high capital
investment and dearth of skilled labors are the major factors that hinder the
market growth. On the contrary, the emerging economies of Asia-Pacific and
LAMEA regions offer lucrative growth opportunities for the expansion of
multiplex assays market, due to improvement in healthcare infrastructure in
these regions and increase in demand for better healthcare services from
majority of the patient population.
The global multiplex
assays market in this report is studied based on type, product,
technology, application, end user, and region. On the basis of type, the market
is divided into nucleic acid-based, protein-based multiplex assays, and others.
By product, it is classified into multiplex assay reagents & consumables,
multiplex assay instruments & accessories, and multiplex assay software
& services. Depending on technology, it is fragmented into nucleic
acid-based, protein-based multiplex assays, and others. As per application, it
is segregated into companion diagnostics, research & development, clinical
diagnostics, and others. According to end user, it is classified into
hospitals, clinical laboratories, research institutes, and pharmaceuticals
& biotechnological companies. Region wise, it is analyzed across North
America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR
STAKEHOLDERS
- The study provides an
in-depth analysis of the global multiplex assay market along with the current
trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the key segments of the industry helps to understand the global trends in the multiplex assay market.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the key segments of the industry helps to understand the global trends in the multiplex assay market.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Type
- Nucleic Acid-based Multiplex Assays
- Protein-based Multiplex Assays
- Others
- Nucleic Acid-based Multiplex Assays
- Protein-based Multiplex Assays
- Others
By Product
- Multiplex Assay Reagents & Consumables
- Multiplex Assay Instruments & Accessories
- Multiplex Assay Software & Services
- Multiplex Assay Reagents & Consumables
- Multiplex Assay Instruments & Accessories
- Multiplex Assay Software & Services
By Technology
- Multiplex PCR
- Multiplex Protein Microarray
- Others
- Multiplex PCR
- Multiplex Protein Microarray
- Others
By Application
- Companion Diagnostics
- Research & Development
- Clinical Diagnostics
- Companion Diagnostics
- Research & Development
- Clinical Diagnostics
By End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceuticals & Biotechnological Companies
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceuticals & Biotechnological Companies
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Saudi Arabia
- South Africa
- Brazil
- Rest of LAMEA
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Saudi Arabia
- South Africa
- Brazil
- Rest of LAMEA
KEY MARKET PLAYERS
- Luminex Corporation
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Becton, Dickinson and Company
- Abcam PLC
- Seegene Inc.
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Becton, Dickinson and Company
- Abcam PLC
- Seegene Inc.
- Randox Laboratories Ltd.
The other players in
the value chain include (profiles not included in the report)
- Merck KGaA
- Agilent Technologies
- Quanterix
- Olink
- Sysmex Corporation
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Agilent Technologies
- Quanterix
- Olink
- Sysmex Corporation
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/5437/multiplex-assay-market-amr
Table Of Content:
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and
Models
CHAPTER 2: EXECUTIVE
SUMMARY
2.1. Key findings of the
study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and
scope
3.2. Key findings
3.2.1. Top investment
pockets
3.3. Porter’s five forces
analysis
3.3.1. Moderate bargaining
power of buyers
3.3.2. Low bargaining
power of suppliers
3.3.3. Moderate threat of
substitutes
3.3.4. Low threat of new
entrants
3.3.5. Moderate
competitive rivalry
3.4. Market share
analysis, 2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in
R&D activities & governmental funding
3.5.1.2. Surge in adoption
of multiplex assays to reduce operation costs
3.5.1.3. Rise in adoption
of personalized medicines
3.5.2. Restraint
3.5.2.1. Lack of skilled
labor/healthcare professionals
3.5.3. Opportunity
3.5.3.1. Various growth
opportunities in emerging economies
CHAPTER 4: MULTIPLEX
ASSAYS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and
forecast
4.2. Nucleic acid-based
multiplex assays
4.2.1. Key market trends
and opportunities
4.2.2. Market size and
forecast
4.2.3. Market share
analysis, by country
4.3. Protein-based
multiplex assays
4.3.1. Key market trends
and opportunities
4.3.2. Market size and
forecast
4.3.3. Market share
analysis, by country
4.4. Others
4.4.1. Key market trends
and opportunities
4.4.2. Market size and
forecast
4.4.3. Market share
analysis, by country
CHAPTER 5: MULTIPLEX
ASSAYS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and
forecast
5.2. Multiplex assays
reagents & consumables
5.2.1. Key market trends,
growth factors, and opportunities
5.2.2. Market size and
forecast
5.2.3. Market share
analysis, by country
5.3. Multiplex assays
instruments & accessories
5.3.1. Key market trends,
growth factors, and opportunities
5.3.2. Market size and
forecast
5.3.3. Market share
analysis, by country
5.4. Multiplex assay
software & services
5.4.1. Key market trends,
growth factors, and opportunities
5.4.2. Market size and
forecast
5.4.3. Market share
analysis, by country
CHAPTER 6: MULTIPLEX
ASSAYS MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and
forecast
6.2. Multiplex PCR
6.2.1. Key market trends,
growth factors, and opportunities
6.2.2. Market size and
forecast
6.2.3. Market share
analysis, by country
6.3. Multiplex protein
microarray
6.3.1. Key market trends,
growth factors, and opportunities
6.3.2. Market size and
forecast
6.3.3. Market share
analysis, by country
6.3.4.
Immunohistochemistry
6.3.4.1. Market size and
forecast
6.4. Other technologies
6.4.1. Key market trends,
growth factors, and opportunities
6.4.2. Market size and
forecast
6.4.3. Market share
analysis, by country
CHAPTER 7: MULTIPLEX
ASSAYS MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and
forecast
7.2. Companion diagnostics
7.2.1. Key market trends,
growth factors, and opportunities
7.2.2. Market size and
forecast
7.2.3. Market share
analysis, by country
7.3. Research &
development
7.3.1. Key market trends,
growth factors, and opportunities
7.3.2. Market size and
forecast
7.3.3. Market share
analysis, by country
7.4. Clinical diagnostics
7.4.1. Key market trends,
growth factors, and opportunities
7.4.2. Market size and
forecast
7.4.3. Market share
analysis, by country
Continue:
About Us:
KD Market Insights offers a comprehensive database of syndicated research
studies, customized reports, and consulting services. These reports are created
to help in making smart, instant and crucial decisions based on extensive and
in-depth quantitative information, supported by extensive analysis and industry
insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (520) 300-1215
No comments:
Post a Comment